SAN DIEGO, Sept. 16, 2010 (GLOBE NEWSWIRE) -- Entest BioMedical, Inc. (OTCBB:ENTB) announced that Chairman and CEO David Koos will be hosting a blogcast on Tuesday, September 21, 2010 at 10:00 a.m. PDT, during which the Company will discuss developments related to its immuno-therapeutic cancer vaccine for dogs, ImenVax™. Areas to be covered include:
